Table 3.
Clinical outcomes | Urokinase-type plasminogen activator (45) | Tissue-type plasminogen activator (41) | p-Value |
---|---|---|---|
Case fatality, n (%) | 6 (13.3) | 5 (12.2) | 0.875 |
GOS | 4.1 ± 0.7 | 3.7 ± 0.9 | 0.178 |
BI | 80.6 ± 17.8 | 76.3 ± 14.1 | 0.434 |
mRS | 2.1 ± 1.0 | 2.3 ± 1.2 | 0.491 |
GOS, Glasgow Outcome Scale; BI, Barthel index; mRS, modified Rankin Scale.